相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Efficacy of rituximab in primary Sjogren's syndrome with peripheral nervous system involvement: results from the AIR registry
A. Mekinian et al.
ANNALS OF THE RHEUMATIC DISEASES (2012)
EULAR Sjogren's Syndrome Patient Reported Index (ESSPRI): development of a consensus patient index for primary Sjogren's syndrome
Raphaele Seror et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
Efficacy and Safety of an Intraoral Electrostimulation Device for Xerostomia Relief A Multicenter, Randomized Trial
Frank P. Strietzel et al.
ARTHRITIS AND RHEUMATISM (2011)
Treatment of Mucosa-associated Lymphoid Tissue Lymphoma in Sjogren's Syndrome: A Retrospective Clinical Study
Rodney P. E. Pollard et al.
JOURNAL OF RHEUMATOLOGY (2011)
Therapeutic Targeting of B Cells for Rheumatic Autoimmune Diseases
Pablo Engel et al.
PHARMACOLOGICAL REVIEWS (2011)
Hydroxychloroquine improves dry eye symptoms of patients with primary Sjogren's syndrome
Sule Yavuz et al.
RHEUMATOLOGY INTERNATIONAL (2011)
EULAR Sjogren's syndrome disease activity index: development of a consensus systemic disease activity index for primary Sjogren's syndrome
Raphaele Seror et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
Effectiveness of Rituximab Treatment in Primary Sjogren's Syndrome A Randomized, Double-Blind, Placebo-Controlled Trial
J. M. Meijer et al.
ARTHRITIS AND RHEUMATISM (2010)
Corneal and Conjunctival Sensitivity in Patients With Dry Eye: The Effect of Topical Cyclosporine Therapy
Ebru Toker et al.
CORNEA (2010)
Treatment Approaches in Primary Sjogren Syndrome
Arjan Vissink et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)
Treatment of Primary Sjogren Syndrome A Systematic Review
Manuel Ramos-Casals et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)
Oral pilocarpine HCl stimulates labial (minor) salivary gland flow in patients with Sjögren's syndrome
NL Rhodus
ORAL DISEASES (2010)
Effects of hydroxychloroquine on salivary flow rates and oral complaints of Sjogren patients: a prospective sample study
Hulya Cankaya et al.
ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTOLOGY (2010)
A Comparison of Vitamin A and Cyclosporine A 0.05% Eye Drops for Treatment of Dry Eye Syndrome
Eun Chul Kim et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2009)
Clinical and Histologic Evidence of Salivary Gland Restoration Supports the Efficacy of Rituximab Treatment in Sjogren's Syndrome
J. Pijpe et al.
ARTHRITIS AND RHEUMATISM (2009)
High-frequency Topical Cyclosporine 0.05% in the Treatment of Severe Dry Eye Refractory to Twice-daily Regimen
Mohammad H. Dastjerdi et al.
CORNEA (2009)
Low Serum Levels of Sex Steroids Are Associated with Disease Characteristics in Primary Sjogren's Syndrome; Supplementation with Dehydroepiandrosterone Restores the Concentrations
Helena Forsblad-d'Elia et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Efficacy and safety of rebamipide for the treatment of dry mouth symptoms in patients with Sjogren's syndrome: a double-blind placebo-controlled multicenter trial
Susumu Sugai et al.
MODERN RHEUMATOLOGY (2009)
Sjogren's syndrome patients presenting with hypergammaglobulinemia are relatively unresponsive to cevimeline treatment
Koichiro Komai et al.
MODERN RHEUMATOLOGY (2009)
Treatment of sicca symptoms with hydroxychloroquine in patients with Sjgrens syndrome
Markus Rihl et al.
RHEUMATOLOGY (2009)
Usefulness of initial histological features for stratifying Sjogren's syndrome responders to mizoribine therapy
Shingo Nakayamada et al.
RHEUMATOLOGY (2009)
Effect of dehydroepiandrosterone administration on fatigue, well-being, and functioning in women with primary Sjogren syndrome: a randomised controlled trial
A. Hartkamp et al.
ANNALS OF THE RHEUMATIC DISEASES (2008)
Reduction of fatigue in Sjogren syndrome with rituximab: results of a randomised, double-blind, placebo-controlled pilot study
S. Dass et al.
ANNALS OF THE RHEUMATIC DISEASES (2008)
Evaluation of topical cyclosporine for the treatment of dry eye disease
Henry D. Perry et al.
ARCHIVES OF OPHTHALMOLOGY (2008)
Parotid Irrigation and Cevimeline Gargle for Treatment of Xerostomia in Sjogren's Syndrome
Yukinori Takagi et al.
JOURNAL OF RHEUMATOLOGY (2008)
Effect of the H2 receptor antagonist nizatidine on xerostomia in patients with primary Sjogren's syndrome
Tsuyoshi Kasama et al.
MODERN RHEUMATOLOGY (2008)
Prognosis of patients with primary Sjogren's syndrome
Pilar Brito-Zeron et al.
MEDICINA CLINICA (2008)
The efficacy of Xialine® in patients with Sjorgren's syndrome:: a single-blind, cross-over study
Esin Alpoz et al.
CLINICAL ORAL INVESTIGATIONS (2008)
The efficacy of cevimeline hydrochloride in the treatment of xerostomia in Sjogren's syndrome in southern Chinese patients: a randomised double-blind, placebo-controlled crossover study
K. C. M. Leung et al.
CLINICAL RHEUMATOLOGY (2008)
Efficacy prediction of cevimeline in patients with Sjogren's syndrome
Hiroyuki Yamada et al.
CLINICAL RHEUMATOLOGY (2007)
Safety and efficacy of leflunomide in primary Sjogren's syndrome: a phase II pilot study
J. M. Van Woerkom et al.
ANNALS OF THE RHEUMATIC DISEASES (2007)
Comparison of topical cyclosporine, punctal occlusion, and a combination for the treatment of dry eye
Calvin W. Roberts et al.
CORNEA (2007)
Comparison of autologous serum and umbilical cord serum eye drops for dry eye syndrome
Kyung-Chul Yoon et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2007)
Proteomic study of salivary peptides and proteins in patients with Sjogren's syndrome before and after pilocarpine treatment
G. Peluso et al.
ARTHRITIS AND RHEUMATISM (2007)
Increase of B cell-activating factor of the TNF family (BAFF) after rituximab treatment: insights into a new regulating system of BAFF production
Frederic Lavie et al.
ANNALS OF THE RHEUMATIC DISEASES (2007)
A controlled release pilocarpine buccal insert in the treatment of Sjogren's syndrome
J. Gibson et al.
BRITISH DENTAL JOURNAL (2007)
Improvement of Sjogren's syndrome after two infusions of rituximab (anti-CD20)
Valerie Devauchelle-Pensec et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2007)
Tolerance and efficacy of rituximab and changes in serum B cell biomarkers in patients with systemic complications of primary Sjogren's syndrome
Raphaele Seror et al.
ANNALS OF THE RHEUMATIC DISEASES (2007)
Recurrence after topical nonpreserved methylprednisolone therapy for keratoconjunctivitis Sicca in Sjogren's syndrome
Samin Hong et al.
JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS (2007)
Pilocarpine treatment in a mixed cohort of xerostomic patients
D. J. Aframian et al.
ORAL DISEASES (2007)
Progression of salivary gland dysfunction in patients with Sjogren's syndrome
J. Pijpe et al.
ANNALS OF THE RHEUMATIC DISEASES (2007)
Mycophenolate sodium treatment in patients with primary Sjogren syndrome: a pilot trial
Peter Willeke et al.
ARTHRITIS RESEARCH & THERAPY (2007)
Pilocarpine hydrochloride for the treatment of xerostomia in patients with Sjogren's syndrome in Taiwan - A double-blind, placebo-controlled trial
Cheng-Han Wu et al.
JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION (2006)
Long term remission of Sjogren's syndrome associated aggressive B cell non-Hodgkin's lymphomas following combined B cell depletion therapy and CHOP (cyclophosphamide, doxorubicin, vincristine, prednisone)
M. Voulgarelis et al.
ANNALS OF THE RHEUMATIC DISEASES (2006)
Conjunctival epithelium improvement after systemic pilocarpine in patients with Sjogren's syndrome
P Aragona et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2006)
Epratuzumab (humanised anti-CD22 antibody) in primary Sjogren's syndrome: an open-label phase I/II study
Serge D. Steinfeld et al.
ARTHRITIS RESEARCH & THERAPY (2006)
Systemic omega-6 essential fatty acid treatment and PGE1 tear content in Sjogren's syndrome patients
P Aragona et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2005)
Phase III safety evaluation of cyclosporine 0.1% ophthalmic emulsion administered twice daily to dry eye disease patients for up to 3 years
LD Barber et al.
OPHTHALMOLOGY (2005)
Rituximab treatment in patients with primary Sjogren's syndrome
J Pijpe et al.
ARTHRITIS AND RHEUMATISM (2005)
Tolerance and short term efficacy of rituximab in 43 patients with systemic autoimmune diseases
JE Gottenberg et al.
ANNALS OF THE RHEUMATIC DISEASES (2005)
Efficacy and safety of 0.18% sodium hyaluronate in patients with moderate dry eye syndrome and superficial keratitis
F Brignole et al.
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2005)
Effects of the topical treatment with NSAIDs on corneal sensitivity and ocular surface of Sjogren's syndrome patients
P Aragona et al.
EYE (2005)
Effect of Cevimeline on salivary components in patients with Sjogren syndrome
K Suzuki et al.
PHARMACOLOGY (2005)
Inefficacy of infliximab in primary Sjogren's syndrome -: Results of the randomized, controlled trial of Remicade in primary Sjogren's syndrome (TRIPSS)
X Mariette et al.
ARTHRITIS AND RHEUMATISM (2004)
A randomized, double-masked, placebo-controlled, multicenter comparison of loteprednol etabonate ophthalmic suspension, 0.5%, and placebo for treatment of keratoconjunctivitis sicca in patients with delayed tear clearance.
SC Pflugfelder et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2004)
Pilot clinical trial of dehydroepiandrosterone (DHEA) versus placebo for Sjogren's Syndrome
SR Pillemer et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2004)
Successful treatment of dry mouth and dry eye symptoms in Sjogren's syndrome patients with oral pilocarpine - A randomized, placebo-controlled, dose-adjustment study
AS Papas et al.
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY (2004)
Etanercept in Sjogren's syndrome - A twelve-week randomized, double-blind, placebo-controlled pilot clinical trial
V Sankar et al.
ARTHRITIS AND RHEUMATISM (2004)
Therapeutic effect of cevimeline on dry eye in patients with Sjogren's syndrome: A randomized, double-blind clinical study
M Ono et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2004)
Clinical manifestations and early diagnosis of Sjogren syndrome
SS Kassan et al.
ARCHIVES OF INTERNAL MEDICINE (2004)
Prominent adverse effects of thalidomide in primary Sjogren's syndrome
SR Pillemer et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2004)
Double-masked, placebo-controlled safety and efficacy trial of diquafosol tetrasodium (INS365) ophthalmic solution for the treatment of dry eye
J Tauber et al.
CORNEA (2004)
Comparison of autologous serum eye drops with conventional therapy in a randomised controlled crossover trial for ocular surface disease
BA Noble et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2004)
The comparison of efficacies of topical corticosteroids and nonsteroidal anti-inflammatory drops on dry eye patients: A clinical and immunocytochemical study
AM Avunduk et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2003)
Treatment of primary Sjogren's syndrome with low-dose human interferon alfa administered by the oromucosal route: Combined phase III results
MJ Cummins et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2003)
Oral pilocarpine for the treatment of ocular symptoms in patients with Sjogren's syndrome: a randomised 12 week controlled study
N Tsifetaki et al.
ANNALS OF THE RHEUMATIC DISEASES (2003)
A pilot study to test the efficacy of oral administration of interferon-alpha lozenges to patients with Sjogren's syndrome
AV Khurshudian
ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTICS (2003)
A randomised, crossover, multicentre study to compare the performance of 0.1% (w/v) sodium hyaluronate with 1.4% (w/v) polyvinyl alcohol in the alleviation of symptoms associated with dry eye syndrome
CC McDonald et al.
EYE (2002)
Sodium hyaluronate eye drops of different osmolarity for the treatment of dry eye in Sjogren's syndrome patients
P Aragona et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2002)
Cevimeline for the treatment of xerostomia in patients with Sjogren syndrome - A randomized trial
RS Fife et al.
ARCHIVES OF INTERNAL MEDICINE (2002)
Usefulness of basal and pilocarpine-stimulated salivary flow in primary Sjogren's syndrome.: Correlation with clinical, immunological and histological features
J Rosas et al.
RHEUMATOLOGY (2002)
Long term treatment with sodium hyaluronate-containing artificial tears reduces ocular surface damage in patients with dry eye
P Aragona et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2002)
A double-blind, randomized, placebo-controlled study of cevimeline in Sjogren's syndrome patients with xerostomia and keratoconjunctivitis sicca
D Petrone et al.
ARTHRITIS AND RHEUMATISM (2002)
Gammalinolenic acid treatment of fatigue associated with primary Sjogren's syndrome
E Theander et al.
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY (2002)
Fibromyalgia in Italian patients with primary Sjogren's syndrome
P Ostuni et al.
JOINT BONE SPINE (2002)
A new system for grading recommendations in evidence based guidelines
R Harbour et al.
BRITISH MEDICAL JOURNAL (2001)
Keratitis, ulceration, and perforation associated with topical nonsteroidal anti-inflammatory drugs
AC Guidera et al.
OPHTHALMOLOGY (2001)
Efficacy and safety of cyclosporin A ophthalmic emulsion in the treatment of moderate-to-severe dry eye disease -: A dose-ranging, randomized trial
D Stevenson et al.
OPHTHALMOLOGY (2000)
Two multicenter, randomized studies of the efficacy and safety of cyclosporine ophthalmic emulsion in moderate to severe dry eye disease
K Sall et al.
OPHTHALMOLOGY (2000)
Diclofenac sodium, 0.1% (Voltaren ophtha), versus sodium chloride, 5%, in the treatment of filamentary keratitis
R Avisar et al.
CORNEA (2000)